Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — taking two doses of Mounjaro at the same time, or twice in one week, is not safe and is not how the medicine works. Mounjaro (tirzepatide) is a once-weekly injection prescribed at a fixed dose set by your prescriber; changing that schedule yourself carries real clinical risks. This page explains why, what to do if you've missed a dose, and how the licensed titration schedule actually moves forward — because those are usually the questions sitting behind this one.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The impulse is understandable. If one weekly dose is good, surely two would get you there faster? In practice, the pharmacology works against that logic entirely. Tirzepatide has a half-life of around five days, meaning significant amounts of the previous dose are still active when your next injection is due. A second dose on top of that does not simply double the effect, it stacks the drug exposure in ways the prescribing data and clinical trials did not study and did not support.
The most immediate risk is a sharp escalation of gastrointestinal side effects: nausea and vomiting severe enough to cause dehydration, which in turn can affect kidney function. The NHS tirzepatide medicines page is clear that these effects are already among the most common reasons people struggle in the early weeks. Adding a second dose does not bypass that adjustment period, it intensifies it. There are also risks around blood glucose, particularly in people who also take other medicines that affect insulin.
The titration schedule (starting at 2.5mg and moving upward in measured steps) exists precisely because the body needs time to adapt. The starter dose is there to let your system settle, not to deliver therapeutic weight loss on its own. Trying to accelerate that by taking more medicine in a shorter window does not replicate a higher dose; it creates an uncontrolled spike. This is covered thoroughly on our Mounjaro treatment page if you want the broader picture on how the medicine works.
This is where most people's real question lives. You've missed your usual day, it's now Wednesday instead of Sunday, and you're wondering whether to take it now, wait, or take two next week. The answer, drawn from the licensed prescribing information, is straightforward: if fewer than four days have passed since your missed dose, take it as soon as you remember and then return to your usual weekly schedule from that point. If more than four days have passed, skip that dose entirely and pick up again on your next scheduled day.
Under no circumstances should you take two doses in a single week to make up for a missed one. That instruction appears in the patient information leaflet for a reason, and it applies regardless of which strength you're on. If you are weighing up whether there is ever a safe exception to this rule, our page on whether you can take two doses of Mounjaro in a week works through the question in detail. The rule is consistent across the full range of licensed strengths.
If you're unsure where you stand or your schedule has become genuinely confusing, that is exactly the kind of question to put to your aftercare team rather than working it out alone. You can reach ours through our contact page, seven days a week. If you are specifically wondering whether taking two doses of 2.5mg is ever acceptable, our page on whether you can take two 2.5mg doses of Mounjaro covers that question in full.
This one comes up a lot, and it deserves a direct answer. The logic seems reasonable, if 5mg is the next step up from 2.5mg, and you have two 2.5mg pens, couldn't you just inject both? No, and not only because of the risks covered above. Each KwikPen contains four weeks of doses at that strength. Taking two injections at once is not pharmacologically equivalent to moving to the next licensed strength, and it is not a sanctioned method of self-titrating.
Dose increases to 5mg and beyond are clinical decisions, made by a prescriber after reviewing how you've responded at your current dose, usually over a minimum of four weeks. The evidence from SURMOUNT-1 (the large phase 3 trial published in the New England Journal of Medicine) showed that the greatest average weight reductions were achieved at 15mg, but those results came through the full structured titration, not through shortcuts. The schedule exists because it produces the best outcomes with the lowest risk of people stopping due to side effects.
If you feel ready to move to 5mg, the right step is to discuss that at your next clinical review, or to contact your prescriber ahead of schedule if you have a clear reason. Our page on Mounjaro 5mg covers what to expect at that dose, and if cost is part of what's driving the question, it's worth reading through our Mounjaro cost page for a realistic picture of private treatment pricing. If you're wondering about the specific scenario of injecting two 2.5mg pens to reach 5mg, we address that directly on this page.
If you have already taken more than your prescribed dose of Mounjaro, do not wait to see how you feel. Contact NHS 111 or go to your nearest urgent treatment centre and tell them what you've taken and when. Severe or persistent stomach pain (especially pain that extends towards your back) is a symptom that always warrants prompt medical attention, as the MHRA highlighted in its January 2026 Drug Safety Update on GLP-1 medicines. Sustained vomiting that prevents you keeping fluids down is another reason to seek help rather than managing at home.
For anything less urgent (confusion about your schedule, side effects that are manageable but concerning, or questions about whether your dose should change) the right route is your prescribing team. At nume, that support runs seven days a week; your consultation isn't a one-off conversation that closes once your pen is dispatched. If you want to understand what a properly supported Mounjaro treatment programme looks like before committing to anything, check your eligibility through a free consultation with our team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.